Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retapamulin PK in Pediatric Skin Infections
NCT00555061Phase 4Completed
- Sponsor
- GSK
- Start
- Sep 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 9
01
Overview
Phase 4, open-label, single-arm trial of retapamulin in bacterial skin infection and impetigo, sponsored by GSK. Primary endpoint: Number of Participants With Measurable Plasma Concentrations. Started Sep 2007; status: completed.
02
Drugs
retapamulin
03
Conditions
bacterial skin infectionimpetigo
Beyond the preview
Go deeper on NCT00555061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00555061.